We are a global leader in delivering customer-centric solutions in the field of Antibody Drug Conjugates (ADCs) and other bioconjugates to global biopharmaceutical companies. 

• ADC Grangemouth Site is successfully audited by US FDA, UK MHRA, Brazil ANVISA, Japan PMDA
• Integrated services from conjugation development to clinical and commercial GMP batch manufacturing and sterile fill/finish

Visit Here: Antibody Body Conjugation Services